Literature DB >> 33519307

Long-Term Clinical Outcomes of Unprotected Left Main Percutaneous Coronary Intervention: A Large Single-Centre Experience.

Lijian Gao1, Zhan Gao1, Ying Song1, Changdong Guan2, Bo Xu2, Jue Chen1, Haibo Liu1, Xuewen Qin1, Min Yao1, Jinqing Yuan1, Yongjian Wu1, Fenghuan Hu1, Jie Qian1, Yida Tang1, Kefei Dou1, Weixian Yang1, Hong Qiu1, Chaowei Mu1, Jun Dai1, Shubin Qiao1, Jilin Chen1, Runlin Gao1, Yuejin Yang1.   

Abstract

AIMS: This study sought to report the 10-year clinical outcomes of patients who underwent unprotected left main (LM) percutaneous coronary intervention (PCI) in a large centre. METHODS AND
RESULTS: A total of 913 consecutive patients who underwent unprotected LM PCI from January 2004 to December 2008 at Fu Wai Hospital were retrospectively analysed; the mean age was 60.0 ± 10.9 years, females accounted for 22% of patients, diabetes was present in 27.7% of patients, and an LM bifurcation lesion occurred in 82.9% of patients. During the median follow-up of 9.7 years, major adverse cardiac or cerebrovascular events (MACCEs) occurred in 25.6% (234) of patients, and the rates of all-cause death, myocardial infarction, and stroke were 14.9%, 11.0%, and 7.1%, respectively. Cardiac death occurred in only 7.9% of patients. The estimated event rate was 41.9% for death/myocardial infarction/any revascularization and 45.9% for death/MI/stroke/any revascularization. Definite/probable stent thrombosis occurred in 4.3% (39) of patients. According to the subgroup analysis, IVUS-guided PCI was associated with less long-term MACCEs. Further multivariate analysis identified that age and LVEF<40% were the only independent predictors for 10-year death. Age, LVEF<40%, creatinine clearance, and incomplete revascularization were independent predictors for death/MI, while a two-stent strategy, diabetes, a transradial approach, and the use of bare metal stents (BMSs) or first-generation drug-eluting stents (DESs) were not.
CONCLUSIONS: Unprotected LM PCI in a large cohort of consecutive patients in a single large centre demonstrated favourable long-term outcomes up to 10 years even with the use of BMSs and first-generation of DESs.
Copyright © 2021 Lijian Gao et al.

Entities:  

Mesh:

Year:  2021        PMID: 33519307      PMCID: PMC7815387          DOI: 10.1155/2021/8829686

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  41 in total

1.  Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study.

Authors:  Jose M de la Torre Hernandez; Felipe Hernández Hernandez; Fernando Alfonso; Jose R Rumoroso; Ramon Lopez-Palop; Mario Sadaba; Pilar Carrillo; Juan Rondan; Iñigo Lozano; Juan M Ruiz Nodar; Jose A Baz; Eduard Fernandez Nofrerias; Fernando Pajin; Tamara Garcia Camarero; Hipolito Gutierrez
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

2.  Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club.

Authors:  Adrian P Banning; Jens Flensted Lassen; Francesco Burzotta; Thierry Lefèvre; Olivier Darremont; David Hildick-Smith; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2019-05-20       Impact factor: 6.534

3.  Fractional flow reserve assessment of left main stenosis in the presence of downstream coronary stenoses.

Authors:  Andy S C Yong; David Daniels; Bernard De Bruyne; Hyun-Sook Kim; Fumiaki Ikeno; Jennifer Lyons; Nico H J Pijls; William F Fearon
Journal:  Circ Cardiovasc Interv       Date:  2013-04-02       Impact factor: 6.546

4.  Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis.

Authors:  Seung-Jung Park; Jung-Min Ahn; Soo-Jin Kang; Sung-Han Yoon; Bon-Kwon Koo; Jong-Young Lee; Won-Jang Kim; Duk-Woo Park; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park
Journal:  JACC Cardiovasc Interv       Date:  2014-08       Impact factor: 11.195

5.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

Authors:  Daniel J F M Thuijs; A Pieter Kappetein; Patrick W Serruys; Friedrich-Wilhelm Mohr; Marie-Claude Morice; Michael J Mack; David R Holmes; Nick Curzen; Piroze Davierwala; Thilo Noack; Milan Milojevic; Keith D Dawkins; Bruno R da Costa; Peter Jüni; Stuart J Head
Journal:  Lancet       Date:  2019-09-02       Impact factor: 79.321

6.  Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.

Authors:  Seung-Jung Park; Young-Hak Kim; Bong-Ki Lee; Seung-Whan Lee; Cheol Whan Lee; Myeong-Ki Hong; Jae-Joong Kim; Gary S Mintz; Seong-Wook Park
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

7.  Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.

Authors:  Duk-Woo Park; Young-Hak Kim; Sung-Cheol Yun; Jong-Young Lee; Won-Jang Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol-Whan Lee; Jae-Joong Kim; Suk-Jung Choo; Cheol-Hyun Chung; Jae-Won Lee; Seong-Wook Park; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2010-10-19       Impact factor: 24.094

8.  Early and mid-term results of drug-eluting stent implantation in unprotected left main.

Authors:  Alaide Chieffo; Goran Stankovic; Erminio Bonizzoni; Eleftheria Tsagalou; Ioannis Iakovou; Matteo Montorfano; Flavio Airoldi; Iassen Michev; Massimo Giuseppe Sangiorgi; Mauro Carlino; Giancarlo Vitrella; Antonio Colombo
Journal:  Circulation       Date:  2005-02-07       Impact factor: 29.690

9.  Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.

Authors:  Young-Hak Kim; Duk-Woo Park; Won-Jang Kim; Jong-Young Lee; Sung-Cheol Yun; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  JACC Cardiovasc Interv       Date:  2010-06       Impact factor: 11.195

10.  Long-term clinical outcomes after a percutaneous coronary intervention with a drug-eluting stent in patients with unprotected left main coronary artery disease excluded from clinical trials.

Authors:  Young Soo Oh; Hyun Jong Lee; Juneyoung Lee; Young Jin Choi; Rak Kyeung Choi; Cheol Woong Yu; Jinsik Park; Jin-Oh Choi; Je Sang Kim; Tae-Hoon Kim; Ho-Jun Jang; Seung Woo Park; Sang Hoon Lee
Journal:  Coron Artery Dis       Date:  2019-06       Impact factor: 1.439

View more
  1 in total

1.  Single versus Double Stenting in NSTEMI Patients with Complex Left Main Bifurcation Disease.

Authors:  Gianluca Rigatelli; Marco Zuin; Filippo Gianese; Dario Adami; Mauro Carraro; Loris Roncon
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.